Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
[Figure: see text].
['Johnston|S Claiborne|SC|0000-0002-2912-0714', 'Amarenco|Pierre|P|0000-0002-3842-1236', 'Aunes|Maria|M|0000-0001-8148-063X', 'Denison|Hans|H|0000-0003-1961-163X', 'Evans|Scott R|SR|0000-0003-3186-172X', 'Himmelmann|Anders|A|', 'Jahreskog|Marianne|M|0000-0001-6446-2325', 'James|Stefan|S|0000-0003-4413-9736', 'Knutsson|Mikael|M|', 'Ladenvall|Per|P|0000-0002-0300-8070', 'Molina|Carlos A|CA|', 'Nylander|Sven|S|0000-0001-7453-8186', 'Röther|Joachim|J|0000-0002-8088-9991', 'Wang|Yongjun|Y|0000-0002-9976-2341', '|||']
aspirin ischemic stroke benefit-risk assessment ischemic attack, transient ticagrelor treatment outcome